Horizon Discovery Group plc (LSE: HZD) ("Horizon", "the Company" or "the Group"), a global leader in the application of gene editing and gene modulation technologies, today announced that it will provide access to a novel base editing technology licensed from Rutgers, The State University of New Jersey, for exclusive use in therapeutic, diagnostic and services applications. This technology is incorporated into Horizons next-generation gene editing platform to enable the development of novel therapeutics that rely on engineering patients cells either directly in the body (gene therapy), or externally before transplanting back into the patient (cell therapy). This platform will also expand the Companys research tools and service provisions.
The Company formed an exclusive partnership with Rutgers in January 2019 to further develop the novel base editing technology invented by Dr. Shengkan Jin, associate professor of pharmacology, and co-inventor Dr. Juan C. Collantes, post-doctoral research fellow at Rutgers Robert Wood Johnson Medical School, and has since been funding research in base editing at the University while undertaking its own evaluation and proof-of-concept studies. Horizon has a number of internal programs designed to accelerate the clinical uptake of this technology and is now seeking 35 partners to assess and shape the development of its Pin-point base editing platform.
Horizon will offer partners access to a novel system that could be used to progress more effective multi-gene knockout cell therapy programs through clinical development with an improved safety profile. Partners will also gain access to the Companys expertise in genome engineering of different cell types, access to early technical data, and influence over the direction of future development.
Base editing is a novel technology for engineering DNA in cells, which the potential to correct certain errors or mutations in the DNA, or inactivate disease-causing genes. Compared with currently available gene editing methodologies such as conventional CRISPR/Cas9, which creates "cuts" in the gene that can lead to adverse or negative effects, this new technology allows for accurate gene editing while reducing unintended genomic changes that could lead to deleterious effects in patients.
Dr. Jonathan Frampton, Corporate Development Partner, Horizon Discovery, said: "The technology could have a significant impact in enabling cell therapies to be progressed through clinical trials and towards commercialization. Horizon is pleased to offer an effective and precise base editing technology and, alongside Rutgers, aims to make base editing available to all appropriate cell and gene therapy companies as well as research departments. Partnering with leading organizations will help us to drive innovation and deliver the best therapy for the patient."
Dr. Shengkan 'Victor' Jin of Rutgers University stated: "The cytidine deaminase version of the technology alone could potentially be used for developing cell therapies such as gene modified cells for sickle cell anemia and beta thalassemia, HIV resistant cells for AIDS, over-the-shelf CAR-T cells for cancer, and MHC-compatible allogenic stem cells for transplantation. Other applications could include use as gene therapies for inherited genetic diseases including antitrypsin deficiency and Duchenne muscular dystrophy. In addition, we intend to take full advantage of the unique modularity and versatility features of Pin-point platform and develop efficient gene inactivation agents for potential treatment of many devastating diseases where the leading causal contributing factors are well defined. At the top of this disease list are Alzheimers disease, amyotrophic lateral sclerosis, and familial hypercholesterinemia."
Dr. S. David Kimball, Senior Vice President for Research and Economic Development at Rutgers University, added: "The gene editing technology developed by Rutgers has the potential to revolutionize how scientists think about their search for better options and outcomes in the treatment of disease. It has the potential to solve some of the most persistent global health challenges. This partnership with Horizon Discovery is paving the way to deliver biotherapies for precision medicine and diagnostics and improve human health. I am proud that Rutgers, together with Horizon, is among the frontrunners in the field of gene editing."
View source version on businesswire.com: https://www.businesswire.com/news/home/20200114005331/en/
Contacts
Zyme Communications (Trade and Regional Media) Lorna CuddonTel: +44 (0)7811 996 942Email: lorna.cuddon@zymecommunications.com
Read this article:
Horizon Discovery to Provide Access to Novel Base Editing Technology - Yahoo Finance
- 2013 New Jersey Stem Cell Research Symposium [Last Updated On: August 22nd, 2014] [Originally Added On: August 22nd, 2014]
- Stem Cells and Cloning - New Jersey Right to Life | Prolife [Last Updated On: August 22nd, 2014] [Originally Added On: August 22nd, 2014]
- Regenexx Stem Cell Procedures - New York and New Jersey ... [Last Updated On: August 22nd, 2014] [Originally Added On: August 22nd, 2014]
- Wise Young, M.D., Ph.D., Announced as 12th New Jersey Symposium on Biomaterials Science Dinner Speaker [Last Updated On: September 4th, 2014] [Originally Added On: September 4th, 2014]
- Stem cell medicine - Worldnews.com [Last Updated On: September 6th, 2014] [Originally Added On: September 6th, 2014]
- Stem Cell Therapy Spine and Joint Bergen County New Jersey [Last Updated On: September 27th, 2014] [Originally Added On: September 27th, 2014]
- Sarah heads to Russia in latest battle in war on MS [Last Updated On: October 5th, 2014] [Originally Added On: October 5th, 2014]
- Frequently Asked Questions [FAQs] - Stem Cell Therapy New ... [Last Updated On: October 27th, 2014] [Originally Added On: October 27th, 2014]
- Targeting cancer stem cells: a new therapy to cure cancer ... [Last Updated On: October 29th, 2014] [Originally Added On: October 29th, 2014]
- Dynamic Imaging System Nets Yale Scientist the 2014 STEM CELLS Young Investigator Award [Last Updated On: December 4th, 2014] [Originally Added On: December 4th, 2014]
- A Few Cells Could Prevent Bone Marrow Transplant Infections [Last Updated On: February 3rd, 2015] [Originally Added On: February 3rd, 2015]
- Stem Cells from Placenta Show Promise for Treating Heart Failure [Last Updated On: February 12th, 2015] [Originally Added On: February 12th, 2015]
- New Jersey Commission Science and Technology Grants - Stem ... [Last Updated On: February 13th, 2015] [Originally Added On: February 13th, 2015]
- FDA Expands Indication for REVLIMID (Lenalidomide) in Combination with Dexamethasone to Include Patients Newly ... [Last Updated On: February 18th, 2015] [Originally Added On: February 18th, 2015]
- ADDING MULTIMEDIA FDA Expands Indication for REVLIMID (Lenalidomide) in Combination with Dexamethasone to Include ... [Last Updated On: February 19th, 2015] [Originally Added On: February 19th, 2015]
- EAT A PEACH | Beneficial Bacteria [Last Updated On: April 7th, 2015] [Originally Added On: April 7th, 2015]
- Orthopedic Stem Cell Solutions at the Spine & Pain Center ... [Last Updated On: May 8th, 2015] [Originally Added On: May 8th, 2015]
- Research at Rutgers | Rutgers University [Last Updated On: October 19th, 2015] [Originally Added On: October 19th, 2015]
- Research Overview | Rutgers Cancer Institute of New Jersey [Last Updated On: October 19th, 2015] [Originally Added On: October 19th, 2015]
- The New Jersey Cord Blood Bank (NJCBB) [Last Updated On: October 19th, 2015] [Originally Added On: October 19th, 2015]
- NJMS Stem Cells - Rutgers New Jersey Medical School [Last Updated On: August 1st, 2016] [Originally Added On: August 1st, 2016]
- New York and New Jersey - Stem Cell Therapy & Platelet ... [Last Updated On: August 1st, 2016] [Originally Added On: August 1st, 2016]
- New results on stem cells ageing - CODIF Recherche et ... [Last Updated On: August 1st, 2016] [Originally Added On: August 1st, 2016]
- Basic Science FAQs - Stem Cell Institute of New Jersey [Last Updated On: October 29th, 2016] [Originally Added On: October 29th, 2016]
- Stem Cell - New Jersey Catholic Conference - Trenton, NJ [Last Updated On: November 23rd, 2016] [Originally Added On: November 23rd, 2016]
- Non-Surgical - The New Jersey Orthopaedic Institute [Last Updated On: November 27th, 2016] [Originally Added On: November 27th, 2016]
- Blood Drive To Honor 2 1/2-year-old Brain Tumor Patient, 4-year-old Lymphoma Patient - TAPinto.net [Last Updated On: July 6th, 2017] [Originally Added On: July 6th, 2017]
- WCT selected to conduct Ph III NurOwn Trial in ALS - OutSourcing-Pharma.com [Last Updated On: July 6th, 2017] [Originally Added On: July 6th, 2017]
- FDA OKs Pfizer drug for rare, fast-killing type of leukemia - New Jersey Herald [Last Updated On: August 24th, 2017] [Originally Added On: August 24th, 2017]
- Celularity, Inc., Accelerates Breakthrough Placental Discovery & Therapeutic Platform - TASS [Last Updated On: August 24th, 2017] [Originally Added On: August 24th, 2017]
- Stem Cell Center Of NJ - New Jersey Stem Cell Therapy [Last Updated On: August 24th, 2017] [Originally Added On: August 24th, 2017]
- Blood Donations Needed During Labor Day Holiday Season - TAPinto.net [Last Updated On: August 29th, 2017] [Originally Added On: August 29th, 2017]
- Taconic, Silverstein to build 150000 s/f life science research center - Real Estate Weekly [Last Updated On: August 29th, 2017] [Originally Added On: August 29th, 2017]
- Blood Donations Needed During Labor Day Holiday Season - TAPinto - TAPinto.net [Last Updated On: August 29th, 2017] [Originally Added On: August 29th, 2017]
- Lab-made "mini organs" helping doctors treat cystic fibrosis - New Jersey Herald [Last Updated On: August 29th, 2017] [Originally Added On: August 29th, 2017]
- Blood Donations Needed Pre and Post Labor Day Holiday - East ... - TAPinto.net [Last Updated On: August 29th, 2017] [Originally Added On: August 29th, 2017]
- National Stem Cell Centers | Stem Cell Therapy in New York ... [Last Updated On: June 20th, 2018] [Originally Added On: June 20th, 2018]
- Regenexx Stem Cell Procedures - New York and New Jersey Metro [Last Updated On: July 15th, 2018] [Originally Added On: July 15th, 2018]
- New York & New Jersey - Stem Cell Therapy & Platelet Rich ... [Last Updated On: July 24th, 2018] [Originally Added On: July 24th, 2018]
- FAQ - Stem Cell Center Of NJ - New Jersey Stem Cell Therapy [Last Updated On: July 29th, 2018] [Originally Added On: July 29th, 2018]
- New Jersey Regenerative Medicine Stem Cell and PRP ... [Last Updated On: September 16th, 2018] [Originally Added On: September 16th, 2018]
- Stem Cells and Cloning | New Jersey Right to Life [Last Updated On: September 16th, 2018] [Originally Added On: September 16th, 2018]
- Cord Blood Storage, NY and NJ | Community Blood Services [Last Updated On: September 20th, 2018] [Originally Added On: September 20th, 2018]
- Stem Cell Therapy in New Jersey | National Stem Cell Centers [Last Updated On: November 13th, 2018] [Originally Added On: November 13th, 2018]
- Do Stem Cells Really Work? - New Jersey Stem Cell Therapy [Last Updated On: December 19th, 2018] [Originally Added On: December 19th, 2018]
- Obtain Stem Cell Therapy in New Jersey - Stem Cell Miami [Last Updated On: February 23rd, 2019] [Originally Added On: February 23rd, 2019]
- PTC Therapeutics Inc. (PTCT) and MacroGenics Inc. (NASDAQ:MGNX) Comparing side by side - MS Wkly [Last Updated On: October 14th, 2019] [Originally Added On: October 14th, 2019]
- Reviewing PTC Therapeutics Inc. (PTCT)'s and Inovio Pharmaceuticals Inc. (NASDAQ:INO)'s results - MS Wkly [Last Updated On: October 14th, 2019] [Originally Added On: October 14th, 2019]
- Comparing of Osmotica Pharmaceuticals plc (OSMT) and VistaGen Therapeutics Inc. (NASDAQ:VTGN) - MS Wkly [Last Updated On: October 14th, 2019] [Originally Added On: October 14th, 2019]
- Reviewing Morphic Holding Inc. (MORF)'s and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)'s results - MS Wkly [Last Updated On: October 14th, 2019] [Originally Added On: October 14th, 2019]
- Reviewing Curis Inc. (CRIS)'s and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)'s results - MS Wkly [Last Updated On: October 14th, 2019] [Originally Added On: October 14th, 2019]
- Comparing of NewLink Genetics Corporation (NLNK) and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) - MS Wkly [Last Updated On: October 14th, 2019] [Originally Added On: October 14th, 2019]
- Comparison of Merus N.V. (MRUS) and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) - MS Wkly [Last Updated On: October 14th, 2019] [Originally Added On: October 14th, 2019]
- Reviewing ImmunoGen Inc. (IMGN)'s and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)'s results - MS Wkly [Last Updated On: November 2nd, 2019] [Originally Added On: November 2nd, 2019]
- On Stage: Allegaeon ready to rock Philly - The Unionville Times [Last Updated On: November 2nd, 2019] [Originally Added On: November 2nd, 2019]
- Reviewing Brainstorm Cell Therapeutics Inc. (BCLI)'s and Pieris Pharmaceuticals Inc. (NASDAQ:PIRS)'s results - MS Wkly [Last Updated On: November 2nd, 2019] [Originally Added On: November 2nd, 2019]
- Contrasting of Brainstorm Cell Therapeutics Inc. (BCLI) and HOOKIPA Pharma Inc. (NASDAQ:HOOK) - MS Wkly [Last Updated On: November 2nd, 2019] [Originally Added On: November 2nd, 2019]
- PTC Therapeutics Inc. (PTCT) and Jounce Therapeutics Inc. (NASDAQ:JNCE) Comparing side by side - FinanceMercury [Last Updated On: November 6th, 2019] [Originally Added On: November 6th, 2019]
- Live Cell Imaging Consumables Market Evolving to a Next-Generation Strategy with New Partnerships, Technologies and Targets by 2023 key players LCC... [Last Updated On: November 6th, 2019] [Originally Added On: November 6th, 2019]
- Contrasting of Spero Therapeutics Inc. (SPRO) and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) - FinanceMercury [Last Updated On: November 6th, 2019] [Originally Added On: November 6th, 2019]
- Reviewing Capricor Therapeutics Inc. (CAPR)'s and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)'s results - FinanceMercury [Last Updated On: November 6th, 2019] [Originally Added On: November 6th, 2019]
- Reviewing Surface Oncology Inc. (SURF)'s and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)'s results - FinanceMercury [Last Updated On: November 6th, 2019] [Originally Added On: November 6th, 2019]
- Reviewing Magenta Therapeutics Inc. (MGTA)'s and PTC Therapeutics Inc. (NASDAQ:PTCT)'s results - FinanceMercury [Last Updated On: November 6th, 2019] [Originally Added On: November 6th, 2019]
- Celgene to Present New and Updated Data on Key Hematology Pipeline Therapies at American Society of Hematology (ASH) 2019 Annual Meeting - Business... [Last Updated On: November 6th, 2019] [Originally Added On: November 6th, 2019]
- Comparing of Rigel Pharmaceuticals Inc. (RIGL) and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) - The Broch Herald [Last Updated On: November 28th, 2019] [Originally Added On: November 28th, 2019]
- Weekly pick of Neuroscience news from around the world - Brain Tumour Research [Last Updated On: November 30th, 2019] [Originally Added On: November 30th, 2019]
- Stemming the Tide Confronting Anti-Semitism in the 21st Century - The Times of Israel [Last Updated On: January 5th, 2020] [Originally Added On: January 5th, 2020]
- Reviewing Phibro Animal Health (NASDAQ:PAHC) & AgeX Therapeutics (NASDAQ:AGE) - Riverton Roll [Last Updated On: January 15th, 2020] [Originally Added On: January 15th, 2020]
- Horizon to provide access to novel base editing technology - SelectScience [Last Updated On: January 15th, 2020] [Originally Added On: January 15th, 2020]
- John Theurer Cancer Center Announces Appointment of Five New Physicians - Newswise [Last Updated On: January 15th, 2020] [Originally Added On: January 15th, 2020]
- Europe's guardian of stem cells and hopes, real and unrealistic - FRANCE 24 [Last Updated On: January 20th, 2020] [Originally Added On: January 20th, 2020]
- TV Guy: A return to history with Auschwitz Untold - New Jersey Herald [Last Updated On: January 27th, 2020] [Originally Added On: January 27th, 2020]
- Musicians and community coming together in Asbury Park to help Point Pleasant 3-year old - Asbury Park Press [Last Updated On: February 12th, 2020] [Originally Added On: February 12th, 2020]
- Are stem cells really the key to making humans live longer? - Wired.co.uk [Last Updated On: February 16th, 2020] [Originally Added On: February 16th, 2020]
- SpaceX set to launch Falcon 9 rocket and Dragon capsule from Cape Canaveral this week - Florida Today [Last Updated On: March 4th, 2020] [Originally Added On: March 4th, 2020]
- CO2 Incubators Market Update: Uncover the Business Strategies of Leaders & Laggards of the Market - 3rd Watch News [Last Updated On: March 6th, 2020] [Originally Added On: March 6th, 2020]
- Genmab Announces U.S. FDA Approval of Subcutaneous Formulation of Daratumumab, DARZALEX FASPRO (daratumumab and hyaluronidase-fihj), for the Treatment... [Last Updated On: May 6th, 2020] [Originally Added On: May 6th, 2020]
- Hitachi Chemical Advanced Therapeutics Solutions and apceth Biopharma GmbH Enter into Strategic Clinical and Commercial Manufacturing Agreements with... [Last Updated On: May 13th, 2020] [Originally Added On: May 13th, 2020]
- CO2 Incubators Market is Expected to Witness a Steady Growth by 2025 - Farmers Ledger [Last Updated On: June 4th, 2020] [Originally Added On: June 4th, 2020]
- Genmab Announces European Marketing Authorization for the Subcutaneous Formulation of DARZALEX (daratumumab) for the Treatment of Patients with... [Last Updated On: June 10th, 2020] [Originally Added On: June 10th, 2020]